Study of FG-4592 to Correct Anemia in New Dialysis Patients
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2016
Price : $35 *
At a glance
- Drugs Roxadustat (Primary) ; Iron
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors FibroGen
- 13 Jun 2014 Last checked against ClinicalTrials.gov record.
- 21 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2014 New trial record